Trial | NCT02238912  Report issue

Title

Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai
Evaluation of Preclinical Toxicity of a Siddha Formulation Kandhaga Rasayanam ( KR ) and Its Therapeutic Efficacy in Padarthamarai ( Dermatophytoses ) by an Open Clinical Trial

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    50
this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )
Study Started
Jun 30
2012
Primary Completion
Apr 30
2014
Last Update
Sep 12
2014
Estimate

Drug kandhaga rasayanam

KANDHAGA RASAYANAM is a siddha herbo mineral drug with sulphur as a sole mineral ingredient. It is chosen from the classic Siddha text Siddha Vaidhya Thirattu.

  • Other names: Siddha herbo mineral drug KR.

Kandhaga Rasayanam- single arm Experimental

Kandhaga Rasayanam- 2grams twice a day for 45 days

Criteria 

Inclusion Criteria:

patients clinically diagnosed with tinea infection.
direct microscopy skin scraping test positive.

Exclusion Criteria:

pregnant or nursing women.
use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.
allergy or hyperensitivity to any component of the drug.
clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.
diabetic patients.
No Results Posted